GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (OTCPK:ABSCF) » Definitions » Other Long-Term Liabilities

AB Science (AB Science) Other Long-Term Liabilities : $13.91 Mil (As of Jun. 2023)


View and export this data going back to 2011. Start your Free Trial

What is AB Science Other Long-Term Liabilities?

AB Science's other long-term liabilities for the quarter that ended in Jun. 2023 was $13.91 Mil.

AB Science's quarterly other long-term liabilities increased from Jun. 2022 ($16.21 Mil) to Dec. 2022 ($17.19 Mil) but then declined from Dec. 2022 ($17.19 Mil) to Jun. 2023 ($13.91 Mil).

AB Science's annual other long-term liabilities declined from Dec. 2020 ($28.03 Mil) to Dec. 2021 ($20.54 Mil) and declined from Dec. 2021 ($20.54 Mil) to Dec. 2022 ($17.19 Mil).

AB Science Other Long-Term Liabilities Historical Data

The historical data trend for AB Science's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AB Science Other Long-Term Liabilities Chart

AB Science Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AB Science Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AB Science Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

AB Science Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of AB Science's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

AB Science (AB Science) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (OTCPK:ABSCF) » Definitions » Other Long-Term Liabilities
Comparable Companies
XPAR:MLCOT XPAR:ALRPD XPAR:EAPI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN
Traded in Other Exchanges
AB:France
Address
3, Avenue George V, Paris, FRA, 75008
Website
https://www.ab-science.com
AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.